Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fate Therapeutics

1.24
-0.0450-3.52%
Volume:720.37K
Turnover:898.04K
Market Cap:141.54M
PE:-0.75
High:1.30
Open:1.28
Low:1.21
Close:1.28
Loading ...
May 03, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 19, 2023

Major Issues Report

8-K - Current report
Apr 19, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 18, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 14, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 22, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 05, 2023

Major Issues Report

8-K - Current report
Nov 07, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2022

Major Issues Report

8-K - Current report
Aug 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 30, 2022

Major Issues Report

8-K - Current report
Jun 13, 2022

Major Issues Report

8-K - Current report
Jun 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans